DS-8201 for metastatic breast cancer?

Posted by All_in_1963 @burrkay, Dec 31, 2019

Hi @burrkay, I have just been reading about this new treatment protocol: Enhertu (trastuzumab deruxtecan) (DS-8201) for the treatment of patients with HER2-positive metastatic breast cancer. I understand that it received accelerated FDA approval due to the promising study results

– Trastuzumab Deruxtecan Receives Accelerated Approval by FDA for HER2+ Breast Cancer https://www.targetedonc.com/news/trastuzumab-deruxtecan-receives-accelerated-approval-by-fda-for-her2-breast-cancer

Do you know someone who is starting this treatment?


Thank you @burrkay and @colleenyoung for posting the question and sharing this new treatment information. Due to recent scans that indicate my cancer is unfortunately and likely progressing, I'm beginning to research new treatment options with my oncologist. My genetic testing indicated HR+ Low Grade Metastatic Ovarian Cancer which is rare and more difficult to find studies and treatments suited directly to this disease. However I've been on 2 breast cancer drugs which was successful until recently due to the HR+ component found often in breast cancer treatments. Any new treatment ideas in these areas are very much appreciated. I'll continue my research, but please do share! Again, I very much appreciate the information.

Please sign in or register to post a reply.
  Request Appointment